下面是小编为大家整理的2021年全球医学趋势调查报告【优秀范文】,供大家参考。
G iv en
tha t
2 0 2 0
w as an
e x tr aordinar y
y ear
globally
due
to
the
pandemic,
mos t
coun tries ar e
seeing
a
decrease
in
tr end
fr om
2 0 19
to
2 0 2 0 .
S ome
coun tries
ar e
e v en
e xpecting
a nega tiv e
tr end
f or
2 0 2 0 .
About the
sur v e y
Willis
T o w ers
W a ts on
conducts
the
Global
Medic al
T r ends Surv e y
ev ery
y ear
be t w een
July and
Sep t ember .
T w o
hundr ed and
eigh ty -s ev en
leading
insur ers
r epr es en ting
7 6
coun tries participa t ed
in
our
20 21
surv e y .
Global
r esults
pr es en t ed
her e ha ve
been
weigh t ed
using
GDP
per
c apita.
The
U . S .
medical tr end
da ta
ar e
dr a wn
fr om
the
Willis
T o w ers
W a ts on
Na tional T r end
Surv e y
r es ear ch.
Figur e
1:
P ar ticipan t
pr o file
Ov er vie w
CO VID- 19
has
undoub t edly
had
a
major
impact
on
pr oject ed medical
tr ends
f or 2020
and
20 21.
Given
tha t
2020
w as an
e xtr aor dinary
y ear
globally
due
t o
the
pandemic,
mos t coun tries
ar e
s eeing
a
decr eas e
in
tr end
fr om
20 19
t o 2020 .
Some
coun tries
ar e
ev en
e xpecting
a
nega tiv e tr end
f or 2020 .
Man y
insur ers
and
emplo y ers
ar e
r eporting
a
decr easing tr end
in
claims
r a tio
in
2020 ,
as mos t
nonur gen t
tr ea tmen ts and
sur geries w er e
dela y ed
especially
be t w een
Mar ch
and
A ugus t .
In
turn,
thes e
dela y s
cr ea t ed
a
need
f or s ome priv a t e
f acilities
t o
mak e
up
f or los t
r ev enue
in
2020 .
The Willis
T o w ers
W a ts on
CO VID- 19
claims
modeler
sugges ts signific an t
vola tility
in
20 21
r esults,
which
ar e
dependen t on
the
impact
o f
CO VID- 19
and
whe ther
or no t
a
vaccine becomes
a v ailable
early
in
the
y ear ,
who
pa y s
f or it
and the
e x t en t
o f
its
a v ailability .
In
addition,
ther e
is
uncertain ty about
how
CO VID- 19
t es ting
and
tr ea tmen t
cos ts
f or 20 21 will con tinue
t o
be
split
be t w een
gov ernmen t ,
insur ers
and
emplo y ers.
F urther uncertain ty
ar ound
medical
tr end
lies
ahead
in
futur e y ears as w e
s tart
t o
s ee
the
true
impact
o f
dela y ed
tr ea tmen t in
2020
and
the
long-t erm
e ff ects
on
thos e
who
con tr act ed CO VID- 19 .
Ne v ertheless, ther e
is
a
silv er lining
her e ,
as CO VID- 19
has
gr ea tly
acceler a t ed
the
adop tion
and
us e
o f t elehealth,
which,
in
turn,
could
help
t o
o ff s e t
thos e
po t en tial
2
willis to w ers w a t son. com
higher
cos ts
and
pr ovide
a
mor e
e fficien t
w a y
f or insur eds t o
access
and
us e
health
c ar e
in
the
futur e .
It
ma y
als o ,
o f cours e ,
incr eas e
utiliza tion
due
t o
eas e
o f
access.
A sia
P acific
Ov er all,
w e
e xpect
pr ojected
global
tr end
to dr op
to
belo w
6%
in
2 0 2 0
be f or e
r ebounding back
to
abo v e
8%
f or
2 0 2 1
due
to
the
c a tch- up
on
dela y ed
tr ea tmen t ,
po ten tially
leading to
worsening
health
conditions and
some unexpected
cos t
incr eases coming
thr ough, such as those
f or
personal pr o tectiv e equipmen t
(PPE).
Figur e
2:
How
do
y ou
e xpect
the
medic al
tr end
in
y our
o v er all book
o f
busines s
to
change
o v er
the
ne x t
thr ee
y ears
compar ed to
curr en t
r a tes ?
0
Global
China .
CO VID- 19
has
no t
had
as much
impact
on
cos t
or utiliza tion
in
China
as it
has
in
o ther
coun tries.
The
cos ts
o f medical
c ar e
con tinue
t o
incr eas e
f or tr ea tmen ts,
particularly thos e
outside
the
s cope
o f
s ocial
s ecurity
cov er age .
The
cen tr al
gov ernmen t
is
planning
t o
elimina t e
the
individual medical
accoun t
and
a t
the
s ame
time
o ffer cov er age
f or outpa tien t
e xpens es
under
s ocial
s ecurity .
The
initiativ e
w as announced
in
Sep t ember
2020 ,
with
mor e
de tails
t o come
on
cov er age .
This
is
e xpect ed
t o
impact
the
cos t
o f tr ea tmen t
in
the
futur e;
how ev er ,
it
will pr obably
tak e
a
while f or the
initiativ e
t o
be
fully implemen t ed
given
the
v aria tion
in gov ernmen t
funding
a t
the
pr o vincial
le v el.
Hong
K ong.
The
lo w
utiliza tion
o f
medical
s ervices
during
the pandemic
and
the
r ecession
f or ec as t ed
b y
the
gov ernmen t ar e
the
t w o
main
driv ers
o f
the
slo w do wn
in
medical
tr end
f or
Latin
Americ a
Asia
P acific
Europe
Middle
East and
A fric a
1%
3%
1%
Significantly
lowe r
4%
1%
2%
L owe r
About
the
same
2020
and
20 21.
Demand
f or medical
t ourism fr om
mainland China
has
als o
dr opped
due
t o
the
tr a v el
r es trictions
and s ocial
unr es t
in
Hong
K ong.
Higher
Significantly
higher
54%
Global
Medic al
T r end
3
30%
63 %
37 %
71%
21 %
6%
39%
49%
11%
11%
87%
The
r egion
sho w s
a
signific an t
dr op
in
tr end
t o
6 .2 % in
2020 ,
but
this
will spring back
abo ve
the
20 19
tr end t o
a
pr oject ed
8.5 %
in
20 21.
%
20%
40%
60%
80%
100%
3%
4%
Figur e
3: G lobal
a v er age
medic al
tr end
r a tes
b y
coun tr y ,
2 0 19
– 2 0 2 1
C oun tr y
G r os s
cos t
tr end
Ne t
cos t
tr end
(o f
gener al
in flation)
2 01 9
2020
2 02 1
2 01 9
2020
2 02 1
Global^
7 .1 6
5.88
8. 12
5. 13
4. 60
6 .1 7 La tin
Americ a^
10 .83
8 .97 13. 63
5 .7 5
6. 62
11. 17
North
Americ a
5.55
2 .7 6
7 .1 3
3. 65
2. 15
5.50
A sia
P acific
7. 4 7 6 .22 8.50
5.88
5. 10
6. 78
E ur ope
5.58
4.2 4
5 .7 6
4 .0 2
3.27
4. 15
Middle
Eas t/ A fric a
8. 65
8. 66
1 0.0 1
7 .39
6 .9 4
6 .9 8
L a tin
Americ a
Ar gen tina *
56 . 99
4 7 .29
60 .50
3. 44
28.85
4 7. 7 5
Barbados
and
Eas t
Caribbean
1 0.0 0
1 0.0 0
1 0.0 0
5. 90
5.54
8.39
Br azil*
11. 96
9 .38
11.5 1
8.23
5.82
8.21
Chile*
4.88
3. 18
4 .07
2. 63
-0 . 19
1. 14
Colombia *
6 .27
6. 89
6. 92
2 .7 5
3.38
3. 71
Cos ta
Ric a *
7. 00
8. 00
9 .25 4. 90
6 .4 6
7. 00
E cuador
12. 00
12. 00
12. 00
11. 73
12. 0 1
10 .84
El
Salv ador *
7. 4 3
1 0.0 0
7. 7 1
7 .35
9. 94
7 .1 1
Gua t emala *
8. 00
8.83
11.8 0
4.30
7. 00
1 0.0 2
Hondur as *
6 .1 7 7. 9 8
9 .67 1.8 0
4.83
6. 69
Me xico *
9 .30
11.50
11. 71
5. 66
8.8 0
8. 93
Nicar agua
1 0.0 0
12. 00
15. 00
4 .6 2
7 .53
11. 04
P anama *
1 0 .67 11. 00
9 .4 0
11. 0 2
11. 91
8. 90
P eru
5. 00
6 .0 0
8. 00
2.8 6
4.29
6 .21
Puert o
Rico
5. 00
-6 . 00
18. 00
4.27
-4. 45
17 .36
T rinidad
and
T obago
1 0.0 0
1 0.0 0
1 0.0 0
9 .0 0
11. 00
8. 72
V ene zuela
85. 00
150 . 00
250 . 00
- 19821. 0 2
- 14850 . 00
- 14 7 50 . 00
Nor th
Americ a
Canada
4. 17
0 .1 3
7. 0 3
2.22
- 0.4 8
5 .7 6
Unit ed
Stat es#
7. 9 1
7. 2 4
7 .30
6 .1 0
6. 62
5. 06
A sia
P acific
A us tr alia
6 .50
6 .0 0
6 .0 0
4.8 9
4.5 7 4. 18
China *
8. 68
9 .1 0
9 .32
5 .7 8
6 .0 6
6 .7 7 Hong
K ong*
8. 16
6 . 24
6 .6 8
5.30
4.2 4
4. 18
India *
7. 8 0
12. 00
1 0.0 0
3.26
8. 66
6 .38
Indonesia*
10 .33
9 .97 12. 00
7. 5 1
7 .1 0
9 .0 6
Mala y sia *
10 . 64
10 .82
12.55
9 .97 10 . 71
9 .7 5
Ne w
Z ealand
5. 60
- 2. 00
2 0.0 0
3. 98
-3.22
18. 6 2
Philippines *
7. 7 5
8.50
8.82
5.27 6. 78
5. 94
Singapor e *
7. 6 7 7. 6 7 8. 17
7 .1 0
7 .84
7. 6 5
South K or ea
7. 00
5. 00
4. 00
6. 62
4. 73
3.55
Sri
Lank a
5. 00
5. 00
5. 00
0 .7 0
0 .34
0 .35
T aiw an *
4. 00
4. 00
4. 00
3. 46
3.50
2.50
Thailand
7. 00
7 .50
8. 00
6 .29
8.56
7. 44
Vie tnam *
12. 93
10 . 13
10 . 15
10 . 13
6 .9 3
6 .25 4
willis to w ers w a t son. com
C oun tr y
G r os s
cos t
tr end
Ne t
cos t
tr end
(o f
gener al
in flation)
2 01 9
2020
2 02 1
2 01 9
2020
2 02 1
E ur ope
B elgium
2. 00
2.50
3. 00
0 .7 5
2.25
1. 91
Cyprus 5. 00
0.0 0
1. 00
4. 44
- 0 .7 0
0.0 0
Denmark
5.50
6 .50
4.50
4 .7 7 5.8 0
3.30
F r ance
4. 17
1. 03
2.30
2.8 7 0 .7 5
1. 60
German y
5. 00
7. 00
7. 00
3. 65
6 .6 8
5.82
Gr eece
4.50
4.50
4 .7 5
3. 98
4. 96
3 . 74
Hungary
1 0.0 0
1 0.0 0
1 0.0 0
6 .6 3
6 .6 6
6 .83
Ir eland
4 .47 1. 43
8.33
3.5 9
1. 03
6 .6 3
Norw a y *
5.27 5. 99
6 .4 3
3. 10
3.5 9
4.23
P oland*
5.85
6 .50
7 .33
3.54
3.28
4 .7 5
P ortugal*
3 .7 9
- 1.83
3 .97 3. 49
- 1. 63
2 .6 2
R omania *
12. 6 2
10 .33
11.50
8 .7 9
8 .0 9
1 0.0 5
Russia
7.25 1 0.0 0
11. 00
2 .7 8
6 .9 1
8 .0 1
Serbia
7 .50
7 .50
15. 00
5. 65
6 .0 6
13. 06
Spain
2.85
1. 93
4 .7 5
2. 15
2.23
4. 10
S w eden
9 .0 0
6 .0 0
7 .50
7 .30
5.54
5 .97 S witz erland
4. 00
1.50
1. 00
3. 64
1.8 9
0.4 0
T urk e y
23.25
17 .50
16 . 00
8 .07
5.50
4. 00
Unit ed
Kingdom
5 .67 6 .33
6 .50
3.88
5. 15
4. 96
Middle
Eas t
and
A fric a
Bahr ain
7. 00
7. 00
7. 00
6 .0 0
4. 40
4.50
Burkina F as o
0 .50
15. 00
1 0.0 0
3. 73
11.8 0
7. 9 0
Camer oon *
3.50
6 .25 4. 00
1. 05
3. 45
1 .7 5
Co t e
d"Iv oir e
15. 00
15. 6 7 18.33
14. 19
14. 4 7 16 . 93
E gyp t*
12. 13
10 .88
12.33
-1 . 7 4
5.0 2
4. 10
Gabon
19 .50
21.50
25. 00
17 . 48
18.50 22. 00
Ghana
12. 17
14. 6 7 17 . 17
4. 96
5.0 1
8 .6 2
Guinea
1 0.0 0
5. 00
3. 00
0 .53
-3.50
-5. 00
Jor dan
7. 00
0.0 0
4. 00
6 .7 0
-0 .20
2. 40
Ke n y a
8.50
6 .50
9 .0 0
3.30
1. 40
4. 00
K uwait
5. 00
7 .50
1 0.0 0
3. 90
7. 00
7. 7 0
Madagas c ar
25. 00
2 0.0 0
3 0.0 0
19 .38
14.50
23.50
Mo zambique
7. 00
5. 00
5. 00
4.22
-0 . 19
-0 . 71
Nigeria
17 .33
14. 6 7 18. 6 7 5. 94
1.27
6 .30
Oman
4.50
4.50
5.50
4.3 7 3.50
2. 10
Saudi
Ar abia
1 0.0 0
1 0.0 0
12. 00
11.21
9 .1 3
1 0.04
Senegal
1 0.0 0
15. 00
15. 00
8. 98
13. 00
13. 0 8
South A fric a
6 .50
6 .0 0
6 .0 0
2.3 7 3.5 7 2.84
T ogo
5. 00
8. 00
1 0.0 0
4.31
6 .0 0
8. 00
Uganda
2 0.0 0
1 0.0 0
15. 00
17 . 13
6 .0 6
10 . 15
Unit ed
Ar ab
Emir a t es
9 .0 0
8. 00
8. 00 ...
推荐访问:2021年全球医学趋势调查报告 调查报告 趋势 优秀